Cited by 115Ovarian function and disordersEndometriosis Research and TreatmentReproductive Health and Technologies

Metformin treatment of polycystic ovary syndrome improves health-related quality-of-life, emotional distress and sexuality

Hahn, Susanne, Benson, Sven, Elsenbruch, Sigrid, Pleger, Katja, Tan, Susanne, Mann, Klaus, Schedlowski, Manfred, van Halteren, Walburga Bering +2 more·2006·Human Reproduction

Abstract

BACKGROUND: In polycystic ovary syndrome (PCOS), changes in physical appearance, menstrual disturbances and infertility result in psychological distress and reduced quality-of-life. Metformin improves biochemical, clinical and reproductive parameters in PCOS women. In a prospective, observational study, we analysed the effects of metformin treatment on health-related quality-of-life (HRQL), emotional well-being and sexuality in PCOS. No placebo-treated control group was included. METHODS: Before, during and after 6 months of treatment, changes in clinical and endocrine parameters, quality-of-life, psychological disturbances and sexuality were assessed in 64 PCOS patients using validated questionnaires (SF-36, SCL-90-R) and visual analogue scales. Patients were also compared with published normative data for the validated questionnaires. RESULTS: During treatment, HRQL, particularly the psychosocial aspects (indicated by significant increases in SF-36 scales Vitality, Social Function, Emotional Role Function, Mental Health, Psychological Sum scale) and emotional well-being (reflected by significant lowering of SCL-90-R scales) improved. These improvements in HRQL were significantly correlated with a reduction in body weight and significantly more pronounced in patients with normalized menstrual cycles. In addition, PCOS women were significantly more satisfied with their sex life and reported higher frequencies of sexual intercourse following treatment. CONCLUSION: Treatment can improve the psychosocial, emotional and psychosexual situation of PCOS patients. Although at least some of these effects may be related to the reduction of individual clinical symptoms (i.e. weight loss, normalization of menstrual disturbances, improvement of acne), this observational study does not allow us to clearly discern the role of symptom constellation and does not preclude non-specific and/or placebo effects. Nevertheless, emotional distress and reduced quality-of-life are clearly not an inevitable consequence of PCOS and should be considered as adjunct treatment goals in future studies.

Integrity signals

Registry

Crossref · 10.1093/humrep/del069

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hahn, S., Benson, S., Elsenbruch, S., Pleger, K., Tan, S., Mann, K., Schedlowski, M., van Halteren, W. B., Kimmig, R., & Janssen, O. E.
Affiliations
  • University of Duisburg-Essen (DE)
  • ETH Zurich (CH)
Corresponding author
Hahn, Susanne
Venue
Human Reproduction
Published
2006-03-20
Volume
21
Issue
7
Pages
1925-1934
ISSN
  • 0268-1161 (ISSN-L)
  • 1460-2350
OpenAlex
W2101411360
Cited by
115
References
51
Citations by year
2026: 3 · 2025: 3 · 2024: 5 · 2023: 6 · 2021: 4 · 2020: 6 · 2019: 5 · 2018: 4 · 2017: 4 · 2016: 6 · 2015: 3 · 2014: 9 · 2013: 7 · 2012: 8
FWCI
9.50
Type
journal article
Language
en
Open access
closed
Locations
  • Human Reproduction (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
Keywords
polycystic ovary syndrome, metformin, health-related quality of life, emotional distress, psychological well-being, sexuality, sexual satisfaction, menstrual irregularity, weight loss, psychosocial outcomes
MeSH terms
Adult, Female, Humans, Metformin, Polycystic Ovary Syndrome, Prospective Studies, Quality of Life, Stress, Psychological, Sexuality

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review